Zota Health Care Limited Stock Price Today (NSE: ZOTA)
Fundamental Score
Zota Health Care Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Zota Health Care Limited share price today is ₹1064.80, up +0.00% on NSE/BSE as of 30 March 2026. Zota Health Care Limited (ZOTA) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹5.00K (Cr). The 52-week high for ZOTA share price is ₹1740.00 and the 52-week low is ₹752.00. The company has a Return on Equity (ROE) of -35.96% and a debt-to-equity ratio of 0.57.
Zota Health Care Limited Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Zota Health Care Limited Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Financial Analysis of Zota Health Care Share Price
The pharmaceutical industry is currently experiencing a period of heightened regulatory scrutiny alongside fluctuating raw material costs, impacting profitability across the board. This analysis provides a financial evaluation of the Zota Health Care share price, currently trading at ₹1284.5. This assessment forms part of a comprehensive 80-parameter fundamental audit personally verified by Sweta Mishra. It aims to provide insights into the company's financial health and relative performance compared to its peers.
A key concern highlighted in this review is the reported Price-to-Earnings (PE) ratio of "None," suggesting a lack of recent profitability or reporting difficulties. Furthermore, the Return on Capital Employed (ROCE) stands at a concerning -16.98%. ROCE is a critical indicator of a company's efficiency in generating profits from its capital. A negative ROCE signals that Zota Health Care is currently destroying value rather than creating it. This significantly weakens the company's economic moat, making it more vulnerable to competition and eroding investor confidence.
Comparing Zota Health Care Limited with peers like
Mankind Pharma Ltd is crucial. While a detailed assessment of Mankind Pharma's management quality is beyond the scope of this specific Zota Health Care analysis, it's generally understood that established players like Mankind Pharma often benefit from experienced leadership teams and well-defined strategic directions. This can lead to better operational efficiency and capital allocation, aspects seemingly challenged at Zota Health Care based on its ROCE. Another peer Balaxi Pharmaceuticals Ltd can also provide a comparison point, in this context.The observed negative ROCE raises significant questions regarding Zota Health Care's operational efficiency, cost management, and capital allocation strategies. A sustained negative ROCE could negatively impact the company's long-term financial stability and its ability to generate shareholder value. Further investigation into the underlying causes of the negative ROCE is warranted to fully understand the risks associated with investing in Zota Health Care. The absence of a PE ratio adds an extra layer of uncertainty to the investment proposition.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Zota Health Care Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ZOTA across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Strong Revenue Growth (91.66%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (25.23% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Balanced Promoter Holding (55.81%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Risk Factors
7 factors identified
Below-Average Return on Equity (-35.96%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-16.98%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (2.90%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Profit Decline Concern (-31.82%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Interest Coverage (-3.98x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-123.55 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 8.44%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Zota Health Care Limited Financial Statements
Comprehensive financial data for Zota Health Care Limited including income statement, balance sheet and cash flow
About ZOTA (Zota Health Care Limited)
Zota Health Care Limited is a dynamic and rapidly expanding pharmaceutical company carving a distinctive niche within the Indian and global healthcare landscape. With a firm commit...ment to improving lives through accessible and affordable medicine, Zota meticulously formulates and produces a diverse range of pharmaceutical solutions. This portfolio encompasses a broad spectrum of therapeutic areas, from mainstream generic medications to specialized nutraceuticals and time-honored ayurvedic remedies. Driven by innovation and a patient-centric approach, Zota endeavors to meet the evolving needs of a diverse population, offering both prescription-based drugs and readily available over-the-counter products designed to promote well-being and address a variety of health concerns. At the heart of Zota's operations lies a state-of-the-art manufacturing infrastructure, meticulously designed to adhere to the most stringent international quality standards. This unwavering dedication to quality assurance permeates every aspect of the company's processes, from raw material sourcing to final product packaging. Beyond manufacturing excellence, Zota distinguishes itself through its robust distribution network, ensuring that its pharmaceutical products reach patients and healthcare providers across various geographical regions. The company prides itself on fostering strong relationships with its stakeholders, including distributors, retailers, and medical professionals, further solidifying its presence and contributing to the overall accessibility of its healthcare solutions. Zota Health Care Limited demonstrates a forward-thinking approach to healthcare delivery, exemplified by its unique retail initiative, DAVAINDIA. This network of retail stores serves as a direct conduit to consumers, providing access to affordable medicines and health-related products. DAVAINDIA stores embody Zota's commitment to empowering individuals to take control of their health and well-being, offering not only pharmaceutical products but also valuable information and support. With a rich heritage rooted in ethical business practices and a clear vision for the future, Zota Health Care Limited is poised to continue its trajectory of growth, impacting lives positively and shaping the future of healthcare.
Company Details
Key Leadership
Corporate Events
ZOTA Share Price: Frequently Asked Questions
What is the current share price of Zota Health Care Limited (ZOTA)?
As of 30 Mar 2026, 12:03 pm IST, Zota Health Care Limited share price is ₹1064.80. The ZOTA stock has a market capitalisation of ₹5.00K (Cr) on NSE/BSE.
Is ZOTA share price Overvalued or Undervalued?
ZOTA share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 31.77x. Based on this relative valuation, the Zota Health Care Limited stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of ZOTA share price?
The 52-week high of ZOTA share price is ₹1740.00 and the 52-week low is ₹752.00. These values are updated daily from NSE/BSE price data.
What factors affect the Zota Health Care Limited share price?
Key factors influencing ZOTA share price include quarterly earnings growth (Sales Growth: 91.66%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Zota Health Care Limited a good stock for long-term investment?
Zota Health Care Limited shows a 5-year Profit Growth of N/A% and an ROE of -35.96%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.57 before investing in ZOTA shares.
How does Zota Health Care Limited compare with its industry peers?
Zota Health Care Limited competes with major peers in the Pharmaceuticals. Investors should compare ZOTA share price P/E of 0.00x and ROE of -35.96% against the industry averages to determine competitive standing.
What is the P/E ratio of ZOTA and what does it mean?
ZOTA share price has a P/E ratio of N/Ax compared to the industry average of 31.77x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is ZOTA performing according to Bull Run's analysis?
ZOTA has a Bull Run fundamental score of 24.8/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does ZOTA belong to?
ZOTA operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Zota Health Care Limited share price.
What is Return on Equity (ROE) and why is it important for ZOTA?
ZOTA has an ROE of -35.96%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Zota Health Care Limited generates profits from shareholders capital.
How is ZOTA debt-to-equity ratio and what does it indicate?
ZOTA has a debt-to-equity ratio of 0.57, which indicates moderate leverage that should be monitored.
What is ZOTA dividend yield and is it a good dividend stock?
ZOTA offers a dividend yield of 0.06%, meaning you receive ₹0.06 annual dividend for every ₹100 invested in Zota Health Care Limited shares.
How has ZOTA share price grown over the past 5 years?
ZOTA has achieved 5-year growth rates of: Sales Growth 25.23%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in ZOTA and why does it matter?
Promoters hold 55.81% of ZOTA shares, with 0.26% pledged. High promoter holding often indicates strong management confidence in Zota Health Care Limited.
What is ZOTA market capitalisation category?
ZOTA has a market capitalisation of ₹4997 crores, placing it in the Small-cap category.
How volatile is ZOTA stock?
ZOTA has a beta of N/A. A beta > 1 suggests the Zota Health Care Limited stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is ZOTA operating profit margin trend?
ZOTA has a 5-year average Operating Profit Margin (OPM) of 2.90%, indicating the company's operational efficiency.
How is ZOTA quarterly performance?
Recent quarterly performance shows Zota Health Care Limited YoY Sales Growth of 91.66% and YoY Profit Growth of -31.82%.
What is the institutional holding pattern in ZOTA?
ZOTA has FII holding of 3.49% and DII holding of 4.95%. Significant institutional holding often suggests professional confidence in the Zota Health Care Limited stock.